Kotak Healthcare Fund Direct Growth
Equity
Direct
Sector - Healthcare
NAV as on 03-10-2024
₹ 13.97
Inception Returns
41.2%
/yr
About the Fund
Kotak Healthcare Fund Direct Growth is an equity fund. This fund was started on 11 December, 2023. The fund is managed by . The fund could potentially beat inflation in the long-run.
Key Parameters
- Kotak Healthcare Fund Direct Growth has ₹375 Cr worth of assets under management (AUM) as on Aug 2024 and is less than category average.
- The fund has an expense ratio 0.7.
Returns
Kotak Healthcare Fund Direct Growth has given a CAGR return of 41.22% since inception.
Holdings
Kotak Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Aurobindo Pharma Ltd, Divi's Laboratories Ltd, Torrent Pharmaceuticals Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
Investment objective of Kotak Healthcare Fund Direct Growth
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. Kotak Healthcare Fund Direct Growth has no lock in period.
Historical NAV & Returns
Fund Overview
| Expense ratio | 0.74% |
Benchmark | S&P BSE Healthcare PR |
| AUM | ₹375 Cr |
| Inception Date | 11 December, 2023 |
| Min Lumpsum/SIP | ₹100/₹100 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 4.89% |
| STCG | Redeeming before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Trailing Returns
as on (03-Oct-24)
Fund Distribution
as on (31-Aug-24)
- This fund’s returns stands at 5.65% whereas the fund’s underlying benchmark Nifty 500 returns stands at 0.97% as on Aug'24
- This fund outperformed Nifty 500 by 4.68% in Aug'24
- AUM of the fund stands at 344.2 Cr as of Aug'24
- AUM has remained same between Aug'24 and Jul'24
Top 2 Sectors in August were Health, Basic Materials
Top Growth Drivers | 1M Return |
|---|---|
 Jubilant Pharmova Ltd | 28.8% |
 Marksans Pharma Ltd | 25.1% |
 Sun Pharmaceuticals Industries Ltd | 5.7% |
Kotak Healthcare Fund Direct Growth Highlights
Very High Risk
About the fund
Fund Allocations
AUM size ₹0 Cr
Expense Ratio 0.74%
Frequently Asked Questions
Kotak Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 3.81% | 3.81% |
6 Month Returns | 23.01% | 23.01% |
1 Year Returns | 0% | 0% |
3 Years Returns | 0% | 0% |
5 Years Returns | 0% | 0% |
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Kotak Healthcare Fund Direct Growth | - | - | - |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Kotak Healthcare Fund Direct Growth | - | - | - |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Kotak Healthcare Fund Direct Growth | - | - | - |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Kotak Healthcare Fund Direct Growth | - | - | - |